Literature DB >> 16273802

A brief introduction to the National Data Bank for Rheumatic Diseases.

F Wolfe1, K Michaud.   

Abstract

The National Data Bank for Rheumatic Diseases (NDB) is a research data bank with a broad agenda and approach to important clinical, regulatory, epidemiological, safety, effectiveness, outcome and patient care questions that cannot be answered by conventional data banks. It has systematic, ongoing quality control programs that assure high quality data. NDB-developed programs result in very efficient analytic capabilities and rapid publication.

Entities:  

Mesh:

Year:  2005        PMID: 16273802

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  12 in total

1.  Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.

Authors:  M Cary Reid; David A Bennett; Wen G Chen; Basil A Eldadah; John T Farrar; Bruce Ferrell; Rollin M Gallagher; Joseph T Hanlon; Keela Herr; Susan D Horn; Charles E Inturrisi; Salma Lemtouni; Yu Woody Lin; Kaleb Michaud; R Sean Morrison; Tuhina Neogi; Linda L Porter; Daniel H Solomon; Michael Von Korff; Karen Weiss; James Witter; Kevin L Zacharoff
Journal:  Pain Med       Date:  2011-08-11       Impact factor: 3.750

2.  Improving survival in inflammatory rheumatic diseases: a neglected goal?

Authors:  Theodore Pincus; Allan Gibofsky; J Timothy Harrington
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

3.  Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Bryant R England; Ted R Mikuls; Harlan Sayles; Grant W Cannon; Brian C Sauer; Michael D George; Liron Caplan; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-12       Impact factor: 4.794

4.  The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.

Authors:  Kevin L Winthrop; Roger Baxter; Liyan Liu; Bentson McFarland; Donald Austin; Cara Varley; LeAnn Radcliffe; Eric Suhler; Dongsoek Choi; Lisa J Herrinton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-12-10       Impact factor: 2.890

5.  Changes in Alcohol Use and Associations With Disease Activity, Health Status, and Mortality in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Bryant R England; Ted R Mikuls; Jesse Y Hsu; Michael D George; Sofia Pedro; Harlan Sayles; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-02-12       Impact factor: 4.794

6.  Development and initial validation of a self-assessed lupus organ damage instrument.

Authors:  Karen H Costenbader; Munther Khamashta; Silvia Ruiz-Garcia; Maria Teresa Perez-Rodriguez; Michelle Petri; Jennifer Elliott; Susan Manzi; Elizabeth W Karlson; Tabitha Turner-Stokes; Bonnie Bermas; Jonathan Coblyn; Elena Massarotti; Peter Schur; Patricia Fraser; Iris Navarro; John G Hanly; Timothy S Shaver; Robert S Katz; Eliza Chakravarty; Paul R Fortin; Martha L Sanchez; Jigna Liu; Kaleb Michaud; Graciela S Alarcón; Frederick Wolfe
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

7.  Comparative effectiveness of rheumatoid arthritis therapies.

Authors:  Axel Finckh
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

8.  Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects.

Authors:  Christopher J Smith; Harlan Sayles; Ted R Mikuls; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2011-10-18       Impact factor: 5.156

9.  Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Andrew Stokes; Sofia Pedro; Ted R Mikuls; Michael George; Bryant R England; Harlan Sayles; Fred Wolfe; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-08-31       Impact factor: 5.178

10.  Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?

Authors:  Sofia Ramiro; Robert Landewé; Désirée van der Heijde; David Harrison; David Collier; Kaleb Michaud
Journal:  RMD Open       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.